Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
0.85
0.04 (4.87%)
At close: Jun 16, 2025, 3:59 PM
0.89
4.76%
Pre-market: Jun 17, 2025, 05:13 AM EDT
Lineage Cell Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
3
Upside
253.23
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| B. Riley Securities | Buy | Maintains | 4 3 | 253.23% | Mar 14, 2025 | |
| D. Boral Capital | Buy | Maintains | 2 2 | 135.49% | Mar 11, 2025 | |
| HC Wainwright & Co. | Buy | Reiterates | 9 9 | 959.70% | Mar 11, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.